226 related articles for article (PubMed ID: 16988542)
21. Association of preoperative depression and survival after resection of malignant brain astrocytoma.
Gathinji M; McGirt MJ; Attenello FJ; Chaichana KL; Than K; Olivi A; Weingart JD; Brem H; Quinones-Hinojosa A
Surg Neurol; 2009 Mar; 71(3):299-303, discussion 303. PubMed ID: 18786716
[TBL] [Abstract][Full Text] [Related]
22. Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience.
Bee PC; Gan GG; Teh A; Haris AR
Med J Malaysia; 2006 Dec; 61(5):547-52. PubMed ID: 17623954
[TBL] [Abstract][Full Text] [Related]
23. Prospective single-arm study of 72 Gy hyperfractionated radiation therapy and combination chemotherapy for anaplastic astrocytomas.
Nomiya T; Nemoto K; Kumabe T; Takai Y; Yamada S
BMC Cancer; 2008 Jan; 8():11. PubMed ID: 18199339
[TBL] [Abstract][Full Text] [Related]
24. [A case of gastric gastrointestinal stromal tumor operated after low-dose chemotherapy with imatinib mesylate].
Hori K; Hanada N; Kusano S; Tsurumoto Y; Sakashita N; Uchino R
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1749-51. PubMed ID: 18931581
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT.
Ditschkowski M; Haferlach C; Schulte C; Trenschel R; Beelen DW
Bone Marrow Transplant; 2009 Aug; 44(4):265-6. PubMed ID: 19234516
[No Abstract] [Full Text] [Related]
26. Distribution of nuclear size and internuclear distance are important criteria for grading astrocytomas.
Nafe R; Van de Nes J; Yan B; Schlote W
Clin Neuropathol; 2006; 25(1):48-56. PubMed ID: 16465775
[TBL] [Abstract][Full Text] [Related]
27. [A comparative study of the treatment of high grade gliomas].
Budke M; Isla-Guerrero A; Pérez-López C; Pérez-Alvarez M; García-Grande A; Bello MJ; Rey J
Rev Neurol; 2003 Nov 16-30; 37(10):912-6. PubMed ID: 14634918
[TBL] [Abstract][Full Text] [Related]
28. Central nervous system metastases from imatinib mesylate resistant gastrointestinal stromal tumor.
Gerin F; Baloglu O; Morgan JA; Kesari S
J Neurooncol; 2007 Apr; 82(2):227-8. PubMed ID: 17106648
[No Abstract] [Full Text] [Related]
29. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
30. Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST.
Pitini V; Arrigo C; Sauta MG; Altavilla G
Leuk Res; 2009 Sep; 33(9):e143-4. PubMed ID: 19443031
[TBL] [Abstract][Full Text] [Related]
31. Imatinib mesylate for the treatment of chronic myeloid leukemia.
Soverini S; Martinelli G; Iacobucci I; Baccarani M
Expert Rev Anticancer Ther; 2008 Jun; 8(6):853-64. PubMed ID: 18533795
[TBL] [Abstract][Full Text] [Related]
32. Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML).
Tsapas A; Vlachaki E; Sarigianni M; Klonizakis F; Paletas K
Leuk Res; 2008 Apr; 32(4):674-5. PubMed ID: 17920117
[No Abstract] [Full Text] [Related]
33. Effects of treatment on long-term survivors with malignant astrocytomas.
Imperato JP; Paleologos NA; Vick NA
Ann Neurol; 1990 Dec; 28(6):818-22. PubMed ID: 2178330
[TBL] [Abstract][Full Text] [Related]
34. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
35. Promyelocytic crisis of chronic myelogenous leukaemia during imatinib mesylate treatment.
Oku E; Imamura R; Nagata S; Takata Y; Seki R; Otsubo K; Hashiguchi M; Osaki K; Yakushiji K; Yoshimoto K; Ogata H; Sata M; Okamura T
Acta Haematol; 2007; 117(4):191-6. PubMed ID: 17170522
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for low-grade gliomas.
Mason WP
Forum (Genova); 2000; 10(2):95-104. PubMed ID: 10875972
[TBL] [Abstract][Full Text] [Related]
37. Revisiting anaplastic astrocytomas II: further characterization of an expansive growth pattern with visually enhanced diffusion tensor imaging.
Guan X; Lai S; Lackey J; Shi J; Techavipoo U; Moulding HD; Flanders AE; Andrews DW
J Magn Reson Imaging; 2008 Dec; 28(6):1322-36. PubMed ID: 19025901
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
[TBL] [Abstract][Full Text] [Related]
39. Management of pilomyxoid astrocytomas: our experience.
Tsugu H; Oshiro S; Yanai F; Komatsu F; Abe H; Fukushima T; Nomura Y; Matsumoto S; Nabeshima K; Takano K; Utsunomiya H
Anticancer Res; 2009 Mar; 29(3):919-26. PubMed ID: 19414328
[TBL] [Abstract][Full Text] [Related]
40. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
